0001674649-23-000001.txt : 20231129 0001674649-23-000001.hdr.sgml : 20231129 20231129085632 ACCESSION NUMBER: 0001674649-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231129 DATE AS OF CHANGE: 20231129 EFFECTIVENESS DATE: 20231129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arrivo BioVentures, LLC CENTRAL INDEX KEY: 0001674649 IRS NUMBER: 300936594 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498306 FILM NUMBER: 231448668 BUSINESS ADDRESS: STREET 1: 9001 AERIAL CENTER PARKWAY STREET 2: SUITE 110 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-753-7067 MAIL ADDRESS: STREET 1: 9001 AERIAL CENTER PARKWAY STREET 2: SUITE 110 CITY: MORRISVILLE STATE: NC ZIP: 27560 D 1 primary_doc.xml X0708 D LIVE 0001674649 Arrivo BioVentures, LLC 3000 RDU Center Drive Suite 130 MORRISVILLE NC NORTH CAROLINA 27560 919-753-7067 DELAWARE None None Limited Liability Company true Stephen E. Butts 3000 RDU Center Drive Suite 130 Morrisville NC NORTH CAROLINA 27560 Executive Officer Karen Adams 3000 RDU Center Drive Suite 130 Morrisville NC NORTH CAROLINA 27560 Executive Officer Biotechnology Decline to Disclose 06b false 2023-11-17 false true false 0 45250000 43194016 2055984 false 58 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Arrivo BioVentures, LLC Stephen E. Butts Stephen E. Butts President 2023-11-27